KR20140058581A - 지연된 약물 방출용 히알루론산 함유 경구 제형 - Google Patents

지연된 약물 방출용 히알루론산 함유 경구 제형 Download PDF

Info

Publication number
KR20140058581A
KR20140058581A KR1020147005084A KR20147005084A KR20140058581A KR 20140058581 A KR20140058581 A KR 20140058581A KR 1020147005084 A KR1020147005084 A KR 1020147005084A KR 20147005084 A KR20147005084 A KR 20147005084A KR 20140058581 A KR20140058581 A KR 20140058581A
Authority
KR
South Korea
Prior art keywords
tablet
capsule
hyaluronic acid
salt
hyaluronate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020147005084A
Other languages
English (en)
Korean (ko)
Inventor
올레 묄러 달
Original Assignee
노보자임스 바이오파마 디케이 에이/에스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노보자임스 바이오파마 디케이 에이/에스 filed Critical 노보자임스 바이오파마 디케이 에이/에스
Publication of KR20140058581A publication Critical patent/KR20140058581A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020147005084A 2011-09-02 2012-08-31 지연된 약물 방출용 히알루론산 함유 경구 제형 Withdrawn KR20140058581A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11179819.5 2011-09-02
EP11179819 2011-09-02
PCT/EP2012/066975 WO2013030348A1 (en) 2011-09-02 2012-08-31 Oral formulations containing hyaluronic acid for sustained drug release

Publications (1)

Publication Number Publication Date
KR20140058581A true KR20140058581A (ko) 2014-05-14

Family

ID=46755026

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147005084A Withdrawn KR20140058581A (ko) 2011-09-02 2012-08-31 지연된 약물 방출용 히알루론산 함유 경구 제형

Country Status (9)

Country Link
US (1) US20140302131A1 (enExample)
EP (1) EP2750665A1 (enExample)
KR (1) KR20140058581A (enExample)
CN (1) CN103781473A (enExample)
AU (1) AU2012300815A1 (enExample)
CA (1) CA2847328A1 (enExample)
IL (1) IL230787A0 (enExample)
IN (1) IN2014CN02343A (enExample)
WO (1) WO2013030348A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114767649A (zh) * 2021-12-22 2022-07-22 北京佗林医药科技有限公司 一种顺式透明质酸六糖的制剂及其制备方法
EP4487834A1 (en) 2023-07-07 2025-01-08 NuPep AS Consensus peptides in hya
EP4487863A1 (en) 2023-07-07 2025-01-08 NuPep AS Consensus peptides in hya for use in treating degenerated joints
EP4739277A1 (en) 2023-07-07 2026-05-13 NuPep AS Consensus peptides in hya

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60251898A (ja) 1984-05-25 1985-12-12 Shiseido Co Ltd 醗酵法によるヒアルロン酸の製造方法
IT1271001B (it) 1994-07-26 1997-05-26 Poli Ind Chimica Spa Procedimento di preparazione di acido ialuronico mediante fermentazione con streptococcus
WO1997028828A1 (en) 1996-02-09 1997-08-14 Amgen Boulder Inc. Composition comprising interleukin-1 inhibitor and controlled release polymer
DK0941349T3 (da) 1996-11-18 2004-02-09 Novozymes Biotech Inc Fremgangsmåde til fremstilling af polypeptider i surfactinmutanter af Bacillusceller
JP4234803B2 (ja) * 1997-10-27 2009-03-04 久光製薬株式会社 薬物放出速度が制御された医薬組成物
ATE284954T1 (de) 1997-10-31 2005-01-15 Univ Oklahoma Hyaluronan synthase gen und seine verwendung
CA2326821C (en) 1998-04-02 2010-09-28 The Board Of Regents Of The University Of Oklahoma Nucleic acid encoding hyaluronan synthase and methods of use
US6444447B1 (en) 1998-11-11 2002-09-03 The Board Of Regents Of The University Of Oklahoma Polymer grafting by polysaccharide synthases
JP2005525091A (ja) 2001-12-21 2005-08-25 ノボザイムス バイオポリマー アクティーゼルスカブ 組換え宿主細胞におけるヒアルロナンの生成方法
WO2003061626A1 (en) 2002-01-18 2003-07-31 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform

Also Published As

Publication number Publication date
CN103781473A (zh) 2014-05-07
EP2750665A1 (en) 2014-07-09
IL230787A0 (en) 2014-03-31
AU2012300815A1 (en) 2014-02-20
CA2847328A1 (en) 2013-03-07
US20140302131A1 (en) 2014-10-09
WO2013030348A1 (en) 2013-03-07
IN2014CN02343A (enExample) 2015-06-19

Similar Documents

Publication Publication Date Title
JP5025066B2 (ja) 徐放性医薬製剤に利用する架橋高アミローススターチとその製造方法
Oliveira et al. Chitosan–pectin multiparticulate systems associated with enteric polymers for colonic drug delivery
KR20190104510A (ko) (r)-2-아미노-3-페닐프로필 카바메이트의 제제
AU2001271481A1 (en) Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
JP2002521346A (ja) 多糖類を利用した大腸選択性薬物伝達組成物および医薬製剤
KR20050083628A (ko) 활성성분의 결장 표적화 전달을 위한 생약 형태
JP2017531637A (ja) プレガバリン徐放性製剤
CN103505453B (zh) 一种奥利司他口服固体制剂及其制备方法
US20240082168A1 (en) Controlled drug release formulation
WO2013030348A1 (en) Oral formulations containing hyaluronic acid for sustained drug release
Godge et al. Colonic delivery of film coated meloxicam tablets using natural polysaccharide polymer mixture
Salunkhe et al. Formulation and in-vitro evaluation of dextrin matrix tablet of ibuprofen for colon specific drug delivery
Deshmukh Development and In‑Vitro Evaluation of Colon Specific Indomethacin Matrix Tablet for the Treatment of Inflammatory Bowel Disease
Prabhu et al. Investigation and comparison of colon specificity of novel polymer khaya gum with guar gum.
Liesiene et al. Application of water-soluble diethylaminoethylcellulose in oral drug delivery systems
CN112770730B (zh) 受控的药物释放制剂
Chourey et al. Formulation and Evaluation of Enteric Coated Matrix Tablets of Mesalamine for Inflammatory Bowel Disease.
CN104546672B (zh) 一种非达霉素肠溶制剂
KHAZIM et al. Formulation of probiotics loaded granules of 5-Amino salicylic acid for colon targeting drug delivery system
Saranya et al. Formulation and Evaluation of Hydrogel for Stomach Specific Drug Delivery of Lamivudine
Sani et al. Exopolysaccharides in Drug Delivery Systems
Prabhu et al. Investigation of colon specificity of novel polymer Khaya gum
Begum et al. Studies on the development and evaluation of colon targeted mesalamine tablets based on Eudragit L100-chitosan interpolyelectrolye complexes
Raghuvanshi et al. Formulation and evaluation of colon targeted dosage form of prednisolone tablet using sterculia gum
Lakshmi et al. Design and evaluation of colon specific drug delivery of naproxen sodium using guar gum and crosslinked guar gum

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140226

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid